Clinical trial
Effects of 14-Day Metformin Withdrawal on OGTT-Derived Insulin Sensitivity in Adults With Metabolic Syndrome: A Randomized Controlled Trial
NCT07659444 is registered in ClinicalTrials.gov with University of Castilla-La Mancha as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of 14-Day Metformin Withdrawal on OGTT-Derived Insulin Sensitivity in Adults With Metabolic Syndrome: A Randomized Controlled Trial
- Lead sponsor
- University of Castilla-La Mancha
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 5, 2026
- Completion date
- September 30, 2026
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glucose intolerance, metabolic syndrome (mets)